BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8471314)

  • 1. T cell response to staphylococcal superantigens by asymptomatic HIV-infected individuals exhibits selective changes in T cell receptor V beta-chain usage.
    Bisset LR; Opravil M; Ludwig E; Fierz W
    AIDS Res Hum Retroviruses; 1993 Mar; 9(3):241-6. PubMed ID: 8471314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superantigen-mediated deletion of specific T cell receptor V beta subsets in the SCID-hu Thy/Liv mouse is induced by staphylococcal enterotoxin B, but not HIV-1.
    Komanduri KV; Salha MD; Sékaly RP; McCune JM
    J Immunol; 1997 Jan; 158(2):544-9. PubMed ID: 8992966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell receptor V beta repertoire in HIV-infection individuals: lack of evidence for selective V beta deletion.
    Boyer V; Smith LR; Ferre F; Pezzoli P; Trauger RJ; Jensen FC; Carlo DJ
    Clin Exp Immunol; 1993 Jun; 92(3):437-41. PubMed ID: 8099857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of staphylococcal enterotoxin B upon the induction of tolerance on peripheral CD4+V beta 8+ and CD8+V beta 8+ T cells.
    Sabapathy TK; Hwang LA; Hui KM
    Cell Immunol; 1994 Oct; 158(1):83-95. PubMed ID: 7916268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superantigen as a modifying factor in HIV infection.
    Kobayashi N; Urasawa S
    Pediatr AIDS HIV Infect; 1996 Jun; 7(3):143-54. PubMed ID: 11361581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
    Brogan PA; Shah V; Klein N; Dillon MJ
    Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
    Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS
    J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superantigen implicated in dependence of HIV-1 replication in T cells on TCR V beta expression.
    Laurence J; Hodtsev AS; Posnett DN
    Nature; 1992 Jul; 358(6383):255-9. PubMed ID: 1630494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of CD4 and CD8 molecules conditions the behavior of V beta + murine thymocytes upon superantigenic challenge.
    Fattorossi A; Baschieri S; Ferlini C; Doria G
    Thymus; 1997; 24(3):133-45. PubMed ID: 9151379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective anergy of V beta 8+ T cells in human immunodeficiency virus-infected individuals.
    Dadaglio G; Garcia S; Montagnier L; Gougeon ML
    J Exp Med; 1994 Feb; 179(2):413-24. PubMed ID: 7905016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evolutionary conserved mechanism of T cell activation by microbial toxins. Evidence for different affinities of T cell receptor-toxin interaction.
    Fleischer B; Gerardy-Schahn R; Metzroth B; Carrel S; Gerlach D; Köhler W
    J Immunol; 1991 Jan; 146(1):11-7. PubMed ID: 1670601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD8 T cell response to staphylococcal enterotoxins.
    Herrmann T; MacDonald HR
    Semin Immunol; 1993 Feb; 5(1):33-9. PubMed ID: 8467093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine AIDS superantigen reactivity of the T cells bearing V beta 5 T cell antigen receptor.
    Kanagawa O; Nussrallah BA; Wiebenga ME; Murphy KM; Morse HC; Carbone FR
    J Immunol; 1992 Jul; 149(1):9-16. PubMed ID: 1351503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal expansion but lack of subsequent clonal deletion of bacterial superantigen-reactive T cells in murine retroviral infection.
    Aoki Y; Hiromatsu K; Usami J; Makino M; Igarashi H; Ogasawara J; Nagata S; Yoshikai Y
    J Immunol; 1994 Oct; 153(8):3611-21. PubMed ID: 7523498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal anergy to staphylococcal enterotoxin B in vivo: selective effects on T cell subsets and lymphokines.
    Baschieri S; Lees RK; Lussow AR; MacDonald HR
    Eur J Immunol; 1993 Oct; 23(10):2661-6. PubMed ID: 8104798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of anergy to the superantigen Staphylococcus enterotoxin B.
    Dannecker G; Schultz H; Mecheri S; Sappler G; Clarke K; Niethammer D; Hoffmann MK
    Immunodeficiency; 1993; 4(1-4):137-9. PubMed ID: 8167688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that induction of tolerance in vivo involves active signaling via a B7 ligand-dependent mechanism: CTLA4-Ig protects V beta 8+ T cells from tolerance induction by the superantigen staphylococcal enterotoxin B.
    Lane P; Haller C; McConnell F
    Eur J Immunol; 1996 Apr; 26(4):858-62. PubMed ID: 8625979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell receptor V alpha 4 is expressed by a subpopulation of V beta 6 T cells that respond to the bacterial superantigen staphylococcal enterotoxin B.
    Borrero H; Donson D; Cervera C; Rexer C; Macphail S
    J Immunol; 1995 May; 154(9):4247-60. PubMed ID: 7722285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of superantigen-induced "anergy" on priming and effector stages of a T cell-dependent antibody response.
    Lussow AR; MacDonald HR
    Eur J Immunol; 1994 Feb; 24(2):445-9. PubMed ID: 8299694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to tolerance induction in the diabetes-prone biobreeding rat as one manifestation of abnormal responses to superantigens.
    Sellins KS; Gold DP; Bellgrau D
    Diabetologia; 1996 Jan; 39(1):28-36. PubMed ID: 8720600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.